Johnson Pharmacare Ltd

Regulation 27 (2) Corporate Governance (2)

1.2023-2024-quarter-3.pdf
2.2023-2024-quarter-2.pdf

Regulation 31 – Shareholding Pattern (2)

1.2023-2024-quarter-3.pdf
2.2023-2024-quarter-2.pdf

Regulation 13 (3) Statement of Investor complaints (2)

1.2023-2024-quarter-3.pdf
2.2023-2024-quarter-2.pdf

Reconciliation of Share Capital Audit (SEBI DP Reg.55A) (2)

1.2023-2024-quarter-3.pdf
2.2023-2024-quarter-2.pdf

Regulation 34 Annual Report (1)

1.2022-2023.pdf

Regulation 33 Financial Results (2)

1.2023-2024-quarter-3.pdf
2.2023-2024-quarter-2.pdf

Corporate Announcements (13)

1.2023-2024-quarter-3.pdf
2.2023-2024-quarter-3.pdf
3.2023-2024-quarter-3.pdf
4.2023-2024-quarter-3.pdf
5.2023-2024-quarter-2.pdf
6.2023-2024-quarter-2.pdf
7.2023-2024-quarter-2.pdf
8.2023-2024-quarter-2.pdf
9.2023-2024-quarter-2.pdf
10.2023-2024.pdf
11.2023-2024.pdf
12.2023-2024.pdf
13.2023-2024.pdf

Registrars

Contact

Mail us at